Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
Organ-on-a-chip academic research is in its blossom. Drug toxicity evaluation is a promising area in which organ-on-a-chip technology can apply. A unique advantage of organ-on-a-chip is the ability to integrate drug metabolism and drug toxic processes in a single device, which facilitates evaluation of toxicity of drug metabolites. Human organ-on-a-chip has been fabricated and used to assess drug toxicity with data correlation with the clinical trial. In this review, we introduced the microfluidic chip models of liver, kidney, heart, nerve, and other organs and multiple organs, highlighting the application of these models in drug toxicity detection. Some biomarkers of toxic injury that have been used in organ chip platforms or have potential for use on organ chip platforms are summarized. Finally, we discussed the goals and future directions for drug toxicity evaluation based on organ-on-a-chip technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 A liver chip system for drug toxicity testing. (A) Specific cell type (human, dog, rat) four-cell culture chip used for drug toxicity test [66]; (B) Perfusion-incubator-liver-chip (PIC) using CO2 gas pressure to drive the perfusion medium, which can be used for chronic toxicity repeated dose drug toxicity tests [67] (C) Liver chip combined with fluorescent probe to track mitochondrial function status in real time to monitor cell viability and metabolic function [68]; (D) Liver chip microdevice with a vascular layer, which is helpful for predicting the mechanism of drug liver toxicity at the microcirculation level [69].](https://figures.cochat.ai/paper-figures/dab1891c2b4447f58d4d5cc748a08042/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-1.jpg)
![Figure 2 A kidney chip system for drug toxicity testing. (A) Design of the human kidney proximal tubule-on-a-chip [77]. (B) Microfluidic device designs for single channel and multi-channel devices, and the final device assembly with notable features marked [81]. (C) Design for the device contains the glomerulus, Bowman’s capsule, proximal renal lumen, and capillary tubules [86].](https://figures.cochat.ai/paper-figures/c3c8407e79f44c1cae50f1fc8fd9a69c/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-2.jpg)
![Figure 3 A heart chip system for drug toxicity testing. (A) Schematic of the first microfluidic devices to CMs anisotropy [91]. (B) Representative tissues in the Biowire II platform [96]. (C) Design of the microfluidic device used for integrated heart/cancer-on-a-chip (iHCC) [98].](https://figures.cochat.ai/paper-figures/7595a99fc7424696b3930f8161f217c4/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-3.jpg)
![Figure 4 Schematic diagram of the research progress of neural chips. (A) The structure of the human brain organoid-on-a-chip to model prenatal nicotine exposure [112]. (B) Three-dimensional brain-on-a-chip with an interstitial level of flow and its application as an in vitro model of Alzheimer’s disease [114]. (C) A 3D microfluidic device to quantify orientational regeneration of injured neurons in AD by natural product concentration gradients [115].](https://figures.cochat.ai/paper-figures/65c715c882604f6c8a32d3946543047e/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-4.jpg)
![Figure 5 Some other-organ-on-a-chip systems for drug toxicity testing. (A) Schematic representation of the 3-lane OrganoPlate gut-on-a-chip model [122]. (B) A microengineered model of human pulmonary edema [127]. (C) Schematic drawing of the preparation of the in vitro blood–brain barrier (BBB) model [132].](https://figures.cochat.ai/paper-figures/40fc30dd7ccb419cb11c9b1436a0558f/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“To solve this problem, researchers developed multiorgan-on-a-chip systems to evaluate the efficacy and off-target toxicity of anticancer therapeutics.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“reconstructed critical functional alveolar-capillary interface in vitro, and they set two lateral micro-chambers into a microfluidic device to simulate pressure-driven stretching of the lungs during breathing [126].”
MethodBhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305 · cited 1×
“Also, it can regulate the oxygenation level, shear stress guarantees the barrier integrity of the cell layer, and it can control cell migration in vitro [5].”
BackgroundKim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
Organoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508 · cited 1×
“Through appropriate growth factor treatment, stem cell differentiation and self-organization into organ-specific cell types and tissues occurs, recreating the structure and function of organs in vitro [10].”
BackgroundCirculating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149 · cited 1×
“miRNA-122, miRNA-192 [26] Genomic markers √”
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice
Huh, D., Leslie, D. C., Matthews, B. D., Fraser, J. P., Jurek, S., Hamilton, G. A., Thorneloe, K. S., McAlexander, M. A., & Ingber, D. E. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004249 · Cited by 993 · cited 2×
“(B) A microengineered model of human pulmonary edema [127].”
BackgroundBiowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes
Nunes, S. S., Miklas, J. W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang, J., Massé, S., Gagliardi, M., Hsieh, A., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2524 · Cited by 952 · cited 1×
“When they contract, they pull the wires to produce a measurable deflection, which is transformed into a heartbeat signature [95].”
Background
Research works printed but not linked: 3
- Liu, 2011, Study on the changes of the electrical activity of neural networks by nanomaterials based on the microelectrode array neural chip, Tianjin Med. J., 39, 135
- Qu, 2018, Study on neurotoxicity model of SD rat neural stem cell evaluation drug, China Pharm. Aff., 32, 1079
- Zheng, X.N. (2010). Study on Cytotoxicity of Quantum Dots based on Cell Chip Platform. [Master’s Thesis, Fudan University].
Cited by
Items 101–143 of 143
Ernst, S. W., Knight, R., Royle, J., & Stephenson, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820493-1.00008-8 · Cited by 3
Lam, P. Y., Kim, S., Jung, H., Cherukuri, R., Menon, R., & Han, A. (2025) · Micro and Nano Systems Letters · doi:10.1186/s40486-025-00246-0 · Cited by 3
“These advanced in vitro systems have been utilized for disease modeling [10–12], drug development [12–15], and chemical toxicity testing [16–18] and also potentially being coupled with artificial intelligence (AI) technology for better data analytics [19, 20].”
Cardiotoxicity: Importance of biomarkers
Kostadinović, J., Popadić, V., Klašnja, S., Klisic, A. N., Kotur‐Stevuljević, J., Andric, Z. G., & Zdravkovic, M. D. (2023) · Arhiv za farmaciju · doi:10.5937/arhfarm73-40534 · Cited by 2
Perfilova, V. N. (2023) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2023-379 · Cited by 2
Cells and tissue-based models as a rational substitute in toxicity testing
Panchal, M., Pawar, V., Mhatre, M., Ingole, S., Polaka, S., Tekade, M., Rajpoot, K., & Tekade, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15840-7.00018-x · Cited by 4
Avatar: The Way of Complex In Vitro Models in Cancer Nanomedicine
Mahadik, K., Dhurde, T., Sivakumar, M. B., & Rao, N. M. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500368 · Cited by 1
Sun, L., Wang, P. J., Lin, X., & Qiu, Y. (2025) · Chinese Journal of Plastic and Reconstructive Surgery · doi:10.1016/j.cjprs.2025.11.003 · Cited by 1
Side effect and toxicity of nanomedicine in cancer treatment
Ali, Z., Fatima, I., Azhar, S., & Din, F. U. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44579-8.00014-x · Cited by 1
Opportunities and challenges for human microphysiological systems in drug development
Rahman, S. M., Krishna, A., Sullenberger, C., Jeong, Y. E., García, M., Bhardwaj, B., Geiger, R. M., Blinova, K., & Ford, K. A. (2024) · ALTEX · doi:10.14573/altex.2409221 · Cited by 16
“Studies suggest that MPS can replicate lung injury caused by certain medications, environmental pollutants, or even potential therapeutic compounds (Kerns et al., 2021; Yang et al., 2023a; Cong et al., 2020).”
Navigating Drug Dynamics: Unleashing On-Chip Pharmacokinetics and Pharmacodynamics
Das, A. K., Mutukuri, R., Chowdhury, N., Paul, D., & Nanjappan, S. K. (2025) · Drug Metabolism and Bioanalysis Letters · doi:10.2174/0118723128377867250225073257 · Cited by 1
Thirapanmethee, K., Keawsomnuk, P., Mad-adam, N., Poonsawaeng, I., Ketsawatsomkron, P., Chomnawang, M. T., Kitisripanya, T., & Muta, K. (2026) · Scientific Reports · doi:10.1038/s41598-026-44626-x · Cited by 1
“However, various OOCs have been designed to support prolonged cell culture 35 , and HepG2 OOCs have been shown to be viable for at least two weeks 39,40 .”
Gupta, P., Gupta, E., Jain, R., & Dandekar, P. P. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115941 · Cited by 1
Novikoff, S., Câmara, N. O. S., & Semedo, P. (2022) · Springer eBooks · doi:10.1007/978-3-031-11570-7_3 · Cited by 1
Shahabipour, F., Mousavi, A., Jafari, A., Savoji, H., Deliorman, M., Sukumar, P., Aldhaher, A., Qasaimeh, M. A., Ertaş, Y. N., & Ashammakhi, N. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823536-2.00013-4 · Cited by 1
Nithikathkul, C., Kijphati, R., Krates, J., Junto, E., Thessingha, C., Aneksak, W., Amornmahaphun, S., Pholputta, L., Noradee, S., Kanjaras, P., et al. (2023) · International Journal of Geoinformatics · doi:10.52939/ijg.v19i8.2785 · Cited by 1
Burgio, S., Gennaro, V., Manna, O. M., Picone, D., Carista, A., & Cappello, F. (2024) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2024.12663 · Cited by 1
Development of a dual flow microfluidic device for the study of barrier systems
Baldwin, L. (2020) · Repository@Hull (Worktribe) (University of Hull) · Cited by 2
Hepatocytes and Endothelial Networks in a Fluid-Based In Vitro Model of Liver Drug Metabolism
Tamai, M., Fujiyama, Y., & Tagawa, Y. (2020) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0226
Insight to Biofabrication of Liver Microtissues for Disease Modeling: Challenges and Opportunities
Dortaj, H., Azarpira, N., & Pakbaz, S. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x257744231009071810
Organ-on-chip models for blood–brain barrier permeability studies
Nilghaz, A., Refaat, A., Peng, B., Tong, Z., & Voelcker, N. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15510-9.00023-2 · Cited by 1
Safety Pharmacology in the Era of Precision Medicine
Al-Mahayri, Z. N., & Nagy, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-73317-9_89-1
Human organs-on-a-chip for biological evaluation
Krishnan, M. J. A., Amir, S., Megha, K. B., Reshma, S. C., Joseph, X., & Mohanan, P. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00017-6
Multiorgans-on-a-chip for acute toxicity
Tasleem, A., Kaushik, M., & Parvez, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00002-4
Organ on a chip in nanotechnology
Świst-Szulik, K. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00032-2
Recent breakthrough in organ-on-a-chip
Mukherjee, A. G., Wanjari, U. R., Bradu, P., Biswas, A., Patil, M., Renu, K., Vellingiri, B., & Gopalakrishnan, A. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00007-3
Lab-on-a-chip – Reform, Perform, and Transform
Parihar, A., Khare, V., & Garg, M. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837673476-00001 · Cited by 1
Safety Pharmacology in the Era of Precision Medicine
Al-Mahayri, Z. N., & Nagy, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_89
Stammzellen: Einsatz in der Nephrologie
Novikoff, S., Câmara, N. O. S., & Semedo, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-65236-3_3
Frazier, K. S., Schiccitano, M. S., Heinz-Taheny, K. M., & Cianciolo, R. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-821045-1.00002-x
Respiratory System-Based In Vitro Antiviral Drug Repurposing Strategies for Sars-Cov-2
Genc, D., Katı, A., Mandal, A. K., Ghorai, S., Salami, H., ElHefnawi, S. N. K., & Altuntaş, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238693125010008
Tumor-on-a-Chip: From Biomimetic Tumor-Immune Microenvironments to Therapeutic Insights
Çetin, Y. (2025) · Biochemistry · doi:10.5772/intechopen.1012047
Lab-on-a-Chip Protocols for Adulterant Detection in Foods
Sunil, A., Shrinidhi, B. S., Jnanesh, B. K., Sivamani, Y., Devendran, R., & Elayaperumal, S. (2025) · Methods and protocols in food science · doi:10.1007/978-1-0716-4787-5_5
Rizfazka, D. A., & Kurniawan, I. (2025) · doi:10.1109/icoict66265.2025.11192875
“Additionally, toxicity results from animal models may not always accurately predict human responses [3].”
AI-Driven Drug Development in Inflammatory Diseases
Esakkimuthu, B., Mani, M., Subramanian, P. D., Balasubramanian, B., Asirvatham, A. R., Philomenathan, A. P. J., Shanmugam, V., & Arumugam, V. A. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3373-5258-9.ch005
Tian, J., Li, M., Zhang, W., Feng, X., Ma, S., Wang, L., Li, W., Lin, J., Wu, Z., & Li, N. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c06862
Self-citationYoshitomi, R., & Sugiura, S. (2026) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2026.01.001
Ethical Challenges and Barriers in Animal Experimentation
Nguyen, T. P. T., & Nguyễn, T. T. C. (2026) · Springer eBooks · doi:10.1007/978-981-92-0038-2_15
Venkat, K. M., Zhang, Z., Zheng, K., Kota, V. G., Leo, H. L., Sun, L., & Yu, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30151-3.00007-3
Toward clone‐on‐a‐chip: Ethical and legal considerations for organ‐on‐a‐chip evolution
Karabekmez, M. E., Ebrahimi, A., Ghorbanpoor, H., Bassous, N. J., Shin, S. R., Zhang, Y. S., & Avcı, H. (2026) · BMEMat · doi:10.1002/bmm2.70096
Consolidated and next-generation models in DDS nanotoxicology assessment: Where do we stand
D’Intino, E., Stacchini, F. R., Fabiano, M. G., Marianecci, C., & Carafa, M. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108598
A modular microfluidic chip unit for multiple-organ-on-chip platform integration and drug screening
Hao, Y.-J., Chen, J.-W., Ke, Y.-W., Zhao, R.-Y., Peng, H.-C., Chu, C.-Y., Yao, B.-Y., Hsiao, W., Hung, M., & Tseng, F. (2026) · The Analyst · doi:10.1039/d6an00510a
Trends in 3D Manufacturing of Microdevices for Biomedical Applications
Barapatre, C., Pandey, R., Thakur, A., Latha, N., Mathur, A. K., & Kant, K. (2026) · Micro · doi:10.3390/micro6040086
Design and engineering of multiorgan systems
Shupe, T. D., Campbell, J., & Atala, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-16110-0.00010-8
Metadata
- Authors
- Cong, Y., Han, X., Wang, Y., Chen, Z., Lu, Y., Liu, T., Wu, Z., Jin, Y., Luo, Y., & Zhang, X.
- Affiliations
- Dalian University of Technology (CN)
- Soochow University (CN)
- Shenzhen University (CN)
- Dalian Institute of Chemical Physics (CN)
- Dalian Medical University (CN)
- Health Science Center, Shenzhen University, Shenzhen 518060, China
- Corresponding author
- Luo, Yong
- Zhang, Xiuli
- Venue
- Micromachines
- Publisher
- MDPI AG
- Published
- 2020-04-03
- Volume
- 11
- Issue
- 4
- Pages
- 381
- ISSN
- 2072-666X (ISSN-L)
- PMC
- PMC7230535
- OpenAlex
- W3014092941
- Cited by
- 140
- References
- 146
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 34 · 2023: 23 · 2022: 21 · 2021: 20 · 2020: 5
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Micromachines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (21675017)
- National Key Research and Development Program of China (2017YFC1702001)
- Shenzhen Fundamental Research and Discipline Layout project (JCYJ2018050815247476)
- China Postdoctoral Science Foundation (21675017)
- Sanming Project of Medicine in Shenzhen (SZSM201612049)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- organ-on-a-chip, microfluidic organ models, drug metabolism, multi-organ-on-a-chip, in vitro toxicity testing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.